Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition Staging

阶段(地层学) 癌症 AJCC分段系统 医学 癌症分期 监测、流行病学和最终结果 流行病学 腺癌 肿瘤科 结直肠癌 癌症登记处 内科学 外科 登台系统 古生物学 生物
作者
J. B. O'Connell,Melinda A. Maggard,Clifford Y. Ko
出处
期刊:Journal of the National Cancer Institute [Oxford University Press]
卷期号:96 (19): 1420-1425 被引量:1557
标识
DOI:10.1093/jnci/djh275
摘要

Background: The recently revised American Joint Committee on Cancer (AJCC) sixth edition cancer staging system increased the stratification within colon cancer stages II and III defined by the AJCC fifth edition system. Using nationally representative Surveillance, Epidemiology, and End Results (SEER) data, we compared survival rates associated with colon cancer stages defined according to both AJCC systems. Methods: Using SEER data (from January 1, 1991, through December 31, 2000), we identified 119 363 patients with colon adenocarcinoma and included all patients in two analyses by stages defined by AJCC fifth and sixth edition systems. Tumors were stratified by SEER’s “extent of disease” and “number of positive [lymph] nodes” coding schemes. Kaplan–Meier analyses were used to compare overall and stage-specific 5-year survival. All statistical tests were two-sided. Results: Overall 5-year survival was 65.2%. According to stages defined by the AJCC fifth edition system, 5-year stage-specific survivals were 93.2% for stage I, 82.5% for stage II, 59.5% for stage III, and 8.1% for stage IV. According to stages defined by the AJCC sixth edition system, 5-year stage-specific survivals were 93.2% for stage I, 84.7% for stage IIa, 72.2% for stage IIb, 83.4% for stage IIIa, 64.1% for stage IIIb, 44.3% for stage IIIc, and 8.1% for stage IV. Under the sixth edition system, 5-year survival was statistically significantly better for patients with stage IIIa colon cancer (83.4%) than for patients with stage IIb disease (72.2%) (P<.001). Conclusions: The AJCC sixth edition system for colon cancer stratifies survival more distinctly than the fifth edition system by providing more substages. The association of stage IIIa colon cancer with statistically significantly better survival than stage IIb in the new system may reflect current clinical practice, in which stage III patients receive chemotherapy but stage II patients generally do not.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
七七发布了新的文献求助10
1秒前
1秒前
量子星尘发布了新的文献求助10
4秒前
NeoWu完成签到,获得积分10
4秒前
6秒前
悦耳笑蓝发布了新的文献求助200
6秒前
小萌完成签到 ,获得积分10
9秒前
Qzy发布了新的文献求助10
10秒前
13秒前
13秒前
无花果应助feihua1采纳,获得10
13秒前
华仔应助肉肉采纳,获得10
14秒前
xiyou完成签到,获得积分10
14秒前
张晓倩发布了新的文献求助10
15秒前
李爱国应助七七采纳,获得10
16秒前
18秒前
hjy发布了新的文献求助10
18秒前
我是老大应助云上人采纳,获得10
19秒前
顾矜应助高兴的友菱采纳,获得10
19秒前
20秒前
柏林寒冬应助半颜采纳,获得30
22秒前
嘿嘿发布了新的文献求助10
25秒前
25秒前
26秒前
28秒前
28秒前
29秒前
云上人发布了新的文献求助10
30秒前
30秒前
田様应助临泉采纳,获得10
31秒前
咕噜仔发布了新的文献求助10
31秒前
顾矜应助科研通管家采纳,获得10
32秒前
风清扬应助科研通管家采纳,获得50
32秒前
ED应助科研通管家采纳,获得30
32秒前
猪猪hero应助科研通管家采纳,获得10
33秒前
岩崖应助科研通管家采纳,获得10
33秒前
从容芮应助科研通管家采纳,获得30
33秒前
桐桐应助科研通管家采纳,获得10
33秒前
猪猪hero应助科研通管家采纳,获得10
33秒前
从容芮应助科研通管家采纳,获得30
33秒前
高分求助中
(禁止应助)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
Organic Chemistry 666
The Netter Collection of Medical Illustrations: Digestive System, Volume 9, Part III - Liver, Biliary Tract, and Pancreas (3rd Edition) 600
Introducing Sociology Using the Stuff of Everyday Life 400
Conjugated Polymers: Synthesis & Design 400
Picture Books with Same-sex Parented Families: Unintentional Censorship 380
Metals, Minerals, and Society 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4254735
求助须知:如何正确求助?哪些是违规求助? 3787552
关于积分的说明 11887191
捐赠科研通 3437757
什么是DOI,文献DOI怎么找? 1886715
邀请新用户注册赠送积分活动 937832
科研通“疑难数据库(出版商)”最低求助积分说明 843522